Purchase Order 36C26322P0372
Award Date 3/7/22
Potential Completion Date 8/1/22
Potential Value $59K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs (VA), to ASD Specialty Healthcare, LLC, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $22,051.39, is for the EMERGENCY procurement of WELIREG 40MG TAB (NDC 00006-5331-01), a pharmaceutical product. The contract does not have a set-aside designation and is scheduled for completion by August 6, 2025....
- The Veterans Integrated Service Network 2 awarded a firm fixed-price purchase order valued at $22.5K to ASD Specialty Healthcare, LLC (doing business as AmerisourceBergen) on January 9, 2026, for patient-specific pharmacy procurement of Belzutifan 40mg. Belzutifan (marketed as Welireg) is an FDA-approved oncology medication used to treat renal cell carcinoma and other cancers. The contract has no set-aside designation and will be performed in West Chester Township, Ohio, with an ultimate...
- This is a $45,829.15 firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to ASD Specialty Healthcare, LLC, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of ADSTILADRIN - RX EMERGENCY pharmaceutical products, with a completion date of March 27, 2024. ASD Specialty Healthcare is a leading provider of specialty pharmaceutical distribution and technology solutions, and has a history of federal...
- The Department of Veterans Affairs Veterans Health Administration awarded a $10,653.95 firm fixed price purchase order to ASD Specialty Healthcare, LLC for the delivery of BALVERSA 5MG tablets. ASD Specialty Healthcare will provide 28 count packages of the specified medication to support VHA's Veterans Integrated Service Network 2, which oversees healthcare facilities in parts of Texas and surrounding states. As a leading distributor of pharmaceuticals and medical supplies for government...
- This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to ASD Specialty Healthcare, LLC (doing business as Amerisourcebergen), a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of 1,000 units of the drug BTG VORAXAZE, with a ceiling value of $138,620.05 and a completion date of September 20, 2025. The contract has no set-aside designation. ASD Specialty Healthcare is an established large business that has extensive...
- The Department of Veterans Affairs awarded a $183,316.60 firm fixed price purchase order to ASD Specialty Healthcare, LLC, a division of Amerisourcebergen Specialty Group, LLC. The contract has a total small business set aside designation. ASD Specialty Healthcare will provide 4 units of Adstiladrin drugs to support patient treatment at the Atlanta VA Health Care System, as specified in the sole source special notice issued by the agency. Each unit contains 2 doses of the pharmaceutical product,...
- This federal contract award is for the provision of pharmaceuticals to the Hines Consolidated Mail Outpatient Pharmacy (CMOP) by the prime contractor, ASD Specialty Healthcare, LLC, a division of Amerisourcebergen Specialty Group, LLC. The contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12, and has a firm fixed price of $277,671.84. There was no set-aside designation for this award. ASD Specialty Healthcare has a...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to ASD Specialty Healthcare, LLC, doing business as Amerisourcebergen, for the emergency supply of the pharmaceutical product nemolizumab (Nemluvio) 30mg injection pens. The contract has a ceiling value of $24,905.28 and a period of performance ending on July 17, 2025. This contract does not have a set-aside designation. ASD Specialty Healthcare, a subsidiary of the larger AmerisourceBergen...
- This federal contract was awarded by the Department of Veterans Affairs Veterans Health Administration to ASD Specialty Healthcare, LLC, a division of Amerisourcebergen Specialty Group, LLC. The $140,130.00 firm fixed price purchase order is to provide COVID-19 treatment remdesivir. The contract has no set-aside designation and is tied to the national interest action code for the Coronavirus COVID-19 response. ASD Specialty Healthcare is known for specialty pharmaceutical distribution and...
- This federal contract award to ASD Specialty Healthcare, LLC, a division of Amerisourcebergen Specialty Group, LLC, is for the delivery of REMDESIVIR, an antiviral medication, to the Department of Veterans Affairs Veterans Health Administration. The contract has a potential value of $135,985.50 and a completion date of September 30, 2021. It was awarded on December 23, 2020 and uses a Firm Fixed Price pricing type. The contract is not designated as a set-aside. As a prime contractor, ASD...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 23 (VISN 23) of the U.S. Department of Veterans Affairs (VA) to ASD Specialty Healthcare, LLC, a large pharmaceutical distribution company that is a subsidiary of AmerisourceBergen Corporation. The contract is for the emergency procurement of 40mg tablets of the cancer drug Welireg (belzutifan) with a ceiling value of $59,277.03 and a period of performance ending on August 1, 2022. ASD Specialty Healthcare, which has a history of providing pharmaceutical products to the VA and other government agencies, will be the sole provider of this critical cancer medication under this award. The contract does not have a set-aside designation.
Generated 8/21/24, 7:18 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | ($59k) | 8/20/24 | |
| Not listed | Not listed | $118.5k | 3/7/22 |